Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021

Fig. 2

Mortalities of patients with acute promyelocytic leukaemia

A. Total number of deaths due to different causes according to the time period studied

B. Early deaths and their respective proportions due to acute promyelocytic leukaemia differentiation syndrome (APL-DS), infections and intracerebral haemorrhage (ICH) of the various parameters studied

C. Early deaths due to ICH, APL-DS and infection in the different time periods studied, according to treatment in academic or non-academic centres

D. Early deaths due to ICH, APL-DS and infections during the first 30 days of presentation

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us